Business / Finance RSS Feed - Business / Finance

Upsher-Smith, Saniona sign drug discovery and development agreement

Upsher-Smith, Saniona sign drug discovery and development agreement

Upsher-Smith Laboratories, Inc., through its wholly-owned subsidiary Proximagen Ltd., and Saniona, a leading biotech company in the field of ion channels, today announce that they have entered into a drug discovery and development collaboration. [More]
CASI Pharmaceuticals receives $10.3 million in strategic financing

CASI Pharmaceuticals receives $10.3 million in strategic financing

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces it has received approximately $10.3 million in a strategic financing previously announced on September 21, 2015. [More]
Professor Graham Boulnois appointed as chairman of Medicines Technologies Catapult

Professor Graham Boulnois appointed as chairman of Medicines Technologies Catapult

Life sciences businessman and academic Professor Graham Boulnois has been appointed as chairman of the Medicines Technologies Catapult, one of the latest technology and innovation centres set to open this year. [More]
Sentry Data Systems announces acquisition of Agilum Healthcare Intelligence

Sentry Data Systems announces acquisition of Agilum Healthcare Intelligence

Today, Sentry Data Systems, Inc. announced its acquisition of Nashville-based Agilum Healthcare Intelligence. Sentry, the 2014 KLAS Category Leader for 340B Management Solutions, is a provider of SaaS-based technology and data analytics solutions that help healthcare organizations manage costs, compliance and outcomes. [More]
Linden Capital Partners acquires Chesapeake

Linden Capital Partners acquires Chesapeake

Chesapeake IRB the leading provider of technology enabled independent institutional review board ("IRB") services to the clinical research industry, is pleased to announce it has been acquired by Linden Capital Partners, a Chicago-based healthcare private equity firm that invests world-class resources in exceptional healthcare companies. [More]
TRL becomes primary distributor of Kirkstall's QuasiVivo system in the US and Canada

TRL becomes primary distributor of Kirkstall's QuasiVivo system in the US and Canada

Triangle Research Labs, LLC and Kirkstall, Ltd, are pleased to announce TRL as the primary distributor of Kirkstall's 3-D cell fluidic culture system, QuasiVivo, in the US and Canada. [More]
Apollo Care Connect acquires Healarium's population health management technology and operating platform

Apollo Care Connect acquires Healarium's population health management technology and operating platform

Apollo Medical Holdings, Inc., an integrated population health management company, is pleased to announce that Apollo Care Connect, a wholly-owned subsidiary of ApolloMed, has acquired the population health management technology and operating platform of Healarium, Inc. [More]
Credit Value Partners closes $12.0 million DIP credit facility with Health Diagnostic Laboratory

Credit Value Partners closes $12.0 million DIP credit facility with Health Diagnostic Laboratory

Credit Value Partners, LP, as agent for funds and accounts under its management ("CVP"), a registered investment advisor specializing in corporate debt investments, announced that it closed a $12.0 million revolving DIP credit facility with Health Diagnostic Laboratory, Inc. [More]
Salvat, Lee's Pharmaceutical partner to market Duoxal ear drops in Greater China

Salvat, Lee's Pharmaceutical partner to market Duoxal ear drops in Greater China

Laboratorios SALVAT, S.A. and Lee's Pharmaceutical (HK) Limited, a wholly-owned subsidiary of Lee's Pharmaceutical Holdings Limited, jointly announced today the signing of an exclusive License and Supply Agreement for the marketing and distribution of Duoxal ear drops (patented combination solution of Ciprofloxacin and Fluocinolone Acetonide) in the People's Republic of China, Hong Kong S.A.R., Macau S.A.R., and Taiwan and an option to add Thailand to the contractual territory. [More]
Henry Schein signs agreement to acquire RxWorks

Henry Schein signs agreement to acquire RxWorks

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today an agreement to acquire RxWorks, Inc., a provider of veterinary practice management software primarily to customers in Australia, New Zealand, the UK and the Netherlands, and other countries around the world. [More]
Accuray announces closing of $70 million straight debt financing agreement with Cerberus

Accuray announces closing of $70 million straight debt financing agreement with Cerberus

Accuray Incorporated announced today it has closed a $70 million straight debt financing agreement with Cerberus Business Finance, LLC, an affiliate of Cerberus Capital Management, L.P. [More]
Syapse closes $25 million Series C funding round

Syapse closes $25 million Series C funding round

Syapse, the leader in precision medicine software, has completed the first close of a $25 million Series C funding round. The financing round is being led by Ascension Ventures, a subsidiary of Ascension, the nation's largest non-profit and Catholic health system. [More]
Strathspey Crown Holdings announces acquisition of Novus Via assets

Strathspey Crown Holdings announces acquisition of Novus Via assets

Strathspey Crown Holdings LLC announced today the acquisition of the portfolio companies of Novus Via LP, a Nevada-based venture capital investment firm focused on end-stage development and commercialization of advanced electromagnetic and electrochemical technologies spanning healthcare, clean energy and coherent acoustics. The terms of the transaction were not disclosed. [More]
Sage Analytics establishes distribution network in South America

Sage Analytics establishes distribution network in South America

Sage Analytics, the developers of portable, laboratory-quality cannabis potency measurement systems, announced it established a distribution network in South America, anchored by Senses Biotech in Uruguay. [More]
AiCure closes $12.25 million in Series A fundraising round

AiCure closes $12.25 million in Series A fundraising round

AiCure, an artificial intelligence company connecting the world's patients to better treatments and improved health, has closed a Series A fundraising round with $12.25 million. The consortium is led by New Leaf Venture Partners, with additional participation from Pritzker Group Venture Capital, Tribeca Venture Partners, and Biomatics Capital, established by Boris Nikolic, former Chief Advisor for Science and Technology to Bill Gates. [More]

Aurora Resurgence announces acquisition of Cardiac Science assets

Aurora Resurgence, an affiliate of Aurora Capital Group, a Los Angeles-based private equity firm managing over $2 billion of assets, is pleased to announce the acquisition of the assets of Cardiac Science Corporation in a court-approved sale. [More]

Metrohm USA and University of Maryland School of Pharmacy form partnership

Metrohm USA and the University of Maryland School of Pharmacy have recently formed a mutually beneficial partnership. The alliance will bring state-of-the-art analytical instrumentation and software to the School to be used by students and faculty in a variety of disciplines. The presence of Metrohm at the School of Pharmacy will foster collaboration between Metrohm scientists and the renowned research and education leaders at the School. Collaborative work is already under way in the laboratory of Dr. Stephen Hoag, Professor of Pharmaceutical Sciences. [More]
F-star signs agreement with AbbVie to discover, develop bispecific antibodies in immuno-oncology

F-star signs agreement with AbbVie to discover, develop bispecific antibodies in immuno-oncology

F-star today announced that it has entered into a collaboration and license agreement with AbbVie to research and develop bispecific antibodies in immuno-oncology. Financial terms were not disclosed. [More]
MiMedx Group agrees to buy Stability Biologics

MiMedx Group agrees to buy Stability Biologics

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that it has signed a definitive agreement to acquire Stability Inc., d/b/a Stability Biologics, a provider of human tissue products to surgeons, facilities and distributors serving the surgical, spine and orthopedics sectors of the healthcare industry. [More]

Avalon Healthcare Solutions receives additional investment from Francisco Partners

Avalon Healthcare Solutions today announced a second round of investment from Francisco Partners. The incremental capital will be used to enhance Avalon's comprehensive laboratory management technology and clinical capabilities, as well as to strengthen growth opportunities. [More]
Advertisement
Advertisement